1. Home
  2. MDXH vs GCV Comparison

MDXH vs GCV Comparison

Compare MDXH & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • GCV
  • Stock Information
  • Founded
  • MDXH 2003
  • GCV 1988
  • Country
  • MDXH Belgium
  • GCV United States
  • Employees
  • MDXH N/A
  • GCV N/A
  • Industry
  • MDXH
  • GCV Finance/Investors Services
  • Sector
  • MDXH
  • GCV Finance
  • Exchange
  • MDXH Nasdaq
  • GCV Nasdaq
  • Market Cap
  • MDXH 78.3M
  • GCV 72.1M
  • IPO Year
  • MDXH 2021
  • GCV N/A
  • Fundamental
  • Price
  • MDXH $2.53
  • GCV $3.99
  • Analyst Decision
  • MDXH Strong Buy
  • GCV
  • Analyst Count
  • MDXH 2
  • GCV 0
  • Target Price
  • MDXH $7.50
  • GCV N/A
  • AVG Volume (30 Days)
  • MDXH 44.6K
  • GCV 57.9K
  • Earning Date
  • MDXH 11-06-2024
  • GCV 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • GCV 13.04%
  • EPS Growth
  • MDXH N/A
  • GCV N/A
  • EPS
  • MDXH N/A
  • GCV N/A
  • Revenue
  • MDXH $80,741,000.00
  • GCV N/A
  • Revenue This Year
  • MDXH $24.45
  • GCV N/A
  • Revenue Next Year
  • MDXH $15.22
  • GCV N/A
  • P/E Ratio
  • MDXH N/A
  • GCV N/A
  • Revenue Growth
  • MDXH 45.51
  • GCV N/A
  • 52 Week Low
  • MDXH $0.35
  • GCV $3.15
  • 52 Week High
  • MDXH $4.64
  • GCV $4.58
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 37.08
  • GCV 62.51
  • Support Level
  • MDXH $2.84
  • GCV $3.90
  • Resistance Level
  • MDXH $2.74
  • GCV $4.34
  • Average True Range (ATR)
  • MDXH 0.12
  • GCV 0.14
  • MACD
  • MDXH -0.05
  • GCV 0.01
  • Stochastic Oscillator
  • MDXH 0.00
  • GCV 56.14

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.

Share on Social Networks: